Edge Medical lists in Hong Kong, raising about HK$1.2B; shares jump 36% on debut

Edge Medical

Shenzhen-based Edge Medical listed on the Hong Kong main board under the rules for pre-profit biotech and medtech firms, raising about HK$1.2 billion. Cornerstone investors included the Abu Dhabi Investment Authority, UBS, Tencent, OrbiMed and ChinaAMC. The company calls itself the first in China, and second worldwide, with approved multi-port, single-port and natural-orifice surgical robots.

• Listed January 8, 2026 on the HKEX main board, stock code 2675.
• Raised about HK$1.2B (roughly US$154M) at HK$43.24 per share.
• Shares opened at HK$59, about 36% above the offer price; the Hong Kong retail tranche was oversubscribed about 1,092 times.
• Underwriters included Morgan Stanley, CICC, GF Securities and CLSA.